Integrated analysis of the genomic instability of PTEN in clinically insignificant and significant prostate cancer

Heterogeneity of PTEN and ERG expression in prostate cancer on core needle biopsies: implications for cancer risk stratification and biomarker sampling

(2015) Rajal B. Shah et al.   HUMAN PATHOLOGY

BIMA V3: an aligner customized for mate pair library sequencing

(2014) Travis M. Drucker et al.   BIOINFORMATICS

PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy

(2014) Tamara L Lotan et al.   MODERN PATHOLOGY

Lineage Relationship of Gleason Patterns in Gleason Score 7 Prostate Cancer

(2013) I. V. Kovtun et al.   CANCER RESEARCH

Genetic Alterations Associated With Progression From Pancreatic Intraepithelial Neoplasia to Invasive Pancreatic Tumor

(2013) Stephen J. Murphy et al.   GASTROENTEROLOGY

Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer

(2012) Antje Krohn et al.   AMERICAN JOURNAL OF PATHOLOGY

Do Adenocarcinomas of the Prostate With Gleason Score (GS)≤6 Have the Potential to Metastasize to Lymph Nodes?

(2012) Hillary M. Ross et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas

(2012) G. Vasmatzis et al.   BLOOD

Mate Pair Sequencing of Whole-Genome-Amplified DNA Following Laser Capture Microdissection of Prostate Cancer

(2012) S. J. Murphy et al.   DNA RESEARCH

Novel, gross chromosomal alterations involving PTEN cooperate with allelic loss in prostate cancer

(2012) Alison H M Reid et al.   MODERN PATHOLOGY

PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade

(2012) Maisa Yoshimoto et al.   MODERN PATHOLOGY

Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasia

(2012) Tamara L Lotan et al.   MODERN PATHOLOGY

PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients

(2011) T. L. Lotan et al.   CLINICAL CANCER RESEARCH

Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer

(2010) A H M Reid et al.   BRITISH JOURNAL OF CANCER

Integrative Genomic Profiling of Human Prostate Cancer

(2010) Barry S. Taylor et al.   CANCER CELL

Molecular genetics of prostate cancer: new prospects for old challenges

(2010) M. M. Shen et al.   GENES & DEVELOPMENT

Subtle variations in Pten dose determine cancer susceptibility

(2010) Andrea Alimonti et al.   NATURE GENETICS

PTENgenomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer

(2009) Kanishka Sircar et al.   JOURNAL OF PATHOLOGY

Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression

(2009) Bo Han et al.   MODERN PATHOLOGY

TMPRSS2-ERG and PTEN loss in prostate cancer

(2009) Jeremy A Squire   NATURE GENETICS

Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

(2009) Brett S Carver et al.   NATURE GENETICS

Is PTEN loss associated with clinical outcome measures in human prostate cancer?

(2008) P McCall et al.   BRITISH JOURNAL OF CANCER

Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome

(2008) Maisa Yoshimoto et al.   MODERN PATHOLOGY

The Pace of Prostatic Intraepithelial Neoplasia Development Is Determined by the Timing of Pten Tumor Suppressor Gene Excision

(2008) H. Artee Luchman et al.   PLoS One